China Medical System Holdings Limited (CMS) has successfully completed its secondary listing on the Singapore Exchange (SGX) Mainboard, with shares closing at S$2.28, marking an 11.2% increase from the opening price of S$2.05. CGS International Securities Singapore acted as the issue manager for this significant listing under the ticker symbol 8A8.
The listing is a strategic move by CMS to expand its footprint across Southeast Asia, using Singapore as a base to enhance its visibility among regional stakeholders. This development underscores CGS International’s role as a key facilitator for Chinese companies entering Asia’s capital markets. Jason Saw, Group Head of Investment Banking at CGS International Securities, stated, “We are honoured to support CMS in its strategic expansion in Southeast Asia through Singapore’s capital markets.”
CGS International, a leading financial services provider, continues to bolster its reputation by supporting cross-border transactions and engaging regional investors. The firm, in collaboration with its parent company China Galaxy Securities, serves nearly 18 million customers worldwide, offering a range of financial services across 15 countries and regions.
The successful listing of CMS not only highlights CGS International’s expertise in cross-border equity offerings but also its commitment to enabling access to Asia’s dynamic growth markets. This move is expected to further solidify CMS’s position in the region and enhance its growth trajectory.
“`
